Questa Capital’s Managing Partners Honored as Top 25 Healthcare Investors in 2022

April 27, 2022

WASHINGTON, DC & SAN FRANCISCO, CA—Questa Capital’s Managing Partners, Ryan Drant and Brad Sloan, were honored on Tuesday with inclusion on GrowthCap Advisory’s list of the Top 25 Healthcare Investors of 2022. Over 800 investors were considered at the start of this year’s nomination process, in which GrowthCap solicited feedback from portfolio company CEOs, peer investment firms and industry colleagues. Awardees demonstrated exceptional performance in the areas of investment selection, value creation, and ESG engagement.

“At Questa Capital, we are passionate about healthcare and we’re on a mission to support the most outstanding innovators and leaders who are building the next generation of growth companies,” noted Drant. “We are honored to be in the position to support these CEOs, founders and their management teams as they set out to improve peoples’ lives by increasing the efficiency and quality of care,” added Sloan.

Drant and Sloan have a combined 47 years of experience investing in and building growth-stage healthcare companies.

About Questa Capital

Questa Capital is a venture growth equity firm focusing on investments in expansion-stage healthcare companies. Questa seeks out disruptive, technology-enabled business models that help improve patient lives, streamline market inefficiencies, and provide better quality care. The firm partners with superior management teams to help build innovative market leaders in the healthcare technology, services and medical devices sectors. Questa is led by industry veterans in healthcare investment and operations who have invested in and advised more than 50 growth-stage companies. More information is available at